WASHINGTON — Several drugmakers are expected to sign pricing agreements with the Trump administration on Friday, according to four people familiar with the plans, who were not authorized to speak publicly. The agreements would be the latest in a series of deals in which pharmaceutical companies agree to lower drug prices and invest more domestically…
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. Today we look at how RFK Jr. is cementing his power and how his department’s policies are leading some scientists to leave the U.S. The need-to-know this morning Cytokinetics said Chinese regulators…
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. Apparently the drunk raccoon I mentioned a few weeks ago is a repeat offender. Onto the biotech news today. STAT+ Exclusive Story Already have an account? Log in This article is exclusive…
This essay is part of a First Opinion series on the future of the National Institutes of Health and American science. Around the world, nations with robust research and development infrastructure race to create therapeutics that meet the needs of their residents. Simply put, they dictate research priorities based on need. During the Covid pandemic,…
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Morning. Today, we discuss the implications of a child’s tragic death after receiving a brain-focused gene therapy, hear Siddhartha Mukherjee opine on why the next frontier in cancer treatment is metabolic, and more. The need-to-know…
Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going. And here is our regular feature in which…
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. I hope my fellow Midwesterners stay warm this weekend. Let’s get into the news today. A new FDA drug regulator will face a distrustful staff On Monday, Tracy Beth Høeg will become acting director…
WASHINGTON — In 2008, Tracy Beth Høeg, then a resident physician and ultramarathon runner, expressed dismay at vice presidential candidate Sarah Palin’s denial of climate change. “To stare such abundant scientific evidence in the face and make the blanket statement that you don’t believe it,” Høeg wrote in her blog. “What will the future of…
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. The obesity data keeps coming this week. We’ll get straight into it. The need-to-know this morning Rezolute said its experimental drug failed to reduce episodes of low blood sugar in patients with…
WASHINGTON — Congress is poised to pass the Biosecure Act after two years of incremental changes that watered down the bill’s curbs on Chinese biotechs and made the law more palatable for U.S. biopharma companies. The House passed a defense budget bill today that includes Biosecure, which restricts how U.S. pharmaceutical and biotechnology companies do…